Delivery Order SPE2DR25D2014-SPE2DR26FA1R1
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML vaccine in syringe form. This firm fixed-price delivery order, valued at $7,588.90, represents a non-set-aside, competitively awarded contract with an ultimate completion date of August 27, 2025. The product will be delivered to the company's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $27,961.22 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML vaccine syringes. The contract, which is non-set-aside and competitively awarded, has a firm fixed price structure with an ultimate completion date of July 28, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete transaction under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes valued at $1,418.82 with a firm fixed price contract type. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The order carries no set-aside designation, demonstrating...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Typhim VI 25 mcg/0.5 ml syringes, valued at $14,975.18 under a firm fixed-price contract type. The order, which represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), is scheduled for completion by December 11, 2025. This delivery order was competitively awarded without set-aside designation and...
- The Defense Logistics Agency awarded a delivery order valued at $1,016.68 to AmerisourceBergen Drug Corp for TYPHIM VI 25 mcg/0.5 mL syringes on December 15, 2025, with completion scheduled for December 16, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and has established itself as a major vendor for...
- The Defense Logistics Agency awarded a $1,936.91 delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on December 12, 2025, with completion expected by December 15, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The vaccine delivery will be performed at the contractor's corporate...
- The Defense Logistics Agency awarded a $1,379.80 delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on August 6, 2025, with an ultimate completion date of August 7, 2025. This firm fixed-price contract represents a non-competitive delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a $3,449 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 through December 2026. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, with a completion date...
- The Defense Logistics Agency awarded a $3,339.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on December 4, 2025, with completion scheduled for December 5, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, serves...
- The Defense Logistics Agency awarded a $5,594.61 delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes. The contract is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of November 17, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FA1R1Delivery Order
On January 7, 2026, the Defense Logistics Agency awarded a $19,635 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes. This non-set-aside contract represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999 and extending through December 2026. The vaccine product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, with a completion date of January 8, 2026. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., serves as a critical pharmaceutical distributor supporting federal medical procurement needs across military and veteran healthcare systems. AmerisourceBergen's comprehensive IDC with DLA enables the company to supply a broad range of pharmaceutical products and medical commodities—including specialty medications, brand-name and generic drugs, vaccines, and medical devices—to support military healthcare programs globally. This delivery order for TYPHIM VI vaccine reflects the company's ongoing role as a prime vendor in the Defense Logistics Agency's pharmaceutical supply chain, supporting the medical needs of the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The competitively awarded contract demonstrates AmerisourceBergen's capability to efficiently fulfill government requirements for essential medical products across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.6k | 1/6/26 |